November 21, 2025

Roswell Park Expands EDDY Program with Region’s First Mobile Screening Center for Breast and Prostate Cancer

Determined to make cancer screening accessible for people across Western New York, Roswell Park Comprehensive Cancer Center is proud to unveil the region’s most comprehensive mobile cancer screening initiative.

Roswell Park Comprehensive Cancer Center

November 21, 2025

Geriatric Assessment–Guided Approach to Treatment Intensity in Older Adults With Acute Myeloid Leukemia

“Pretreatment geriatric assessment in older adults with acute myeloid leukemia is feasible, can identify several functional impairments, and [can] guide the selection of treatment intensity,” resultin...

The ASCO Post

November 21, 2025

Reducing the Barriers to Receiving CAR T-Cell Therapy for Patients With Hematologic Malignancies

Chimeric antigen receptor (CAR) T-cell therapy has transformed treatment for patients with hematologic malignancies, achieving unprecedented responses in some patients, especially those diagnosed with...

The ASCO Post

November 20, 2025

Realizing the Full Potential of Patient Engagement in Clinical Research

Nothing about us without us is a centuries-old value that is a cornerstone of meaningful patient engagement in clinical research. Such engagement has not been automatic and is still largely absent in ...

The ASCO Post

November 19, 2025

Reflections of a Medical Oncologist: Empathy Matters in Caring for Patients With Cancer

“Someday you will be a doctor, Fazlur, and help people,” were the prophetic words of a mother to her son and the driving force behind the early quest of Fazlur Rahman, MD, to become a physician. Born ...

The ASCO Post

November 19, 2025

How the Proliferation of Fraudulent Scientific Papers Is Threatening the Integrity of Cancer Research

There is a perception among many scientists that scientific fraud is a rare occurrence, resulting from the actions of a few isolated bad actors. However, an extensive investigation by Reese A.K. Richa...

The ASCO Post

November 19, 2025

Cognitive Function and Statin Administration During Doxorubicin-Based Cancer Treatment

Contrary to previous research, a preplanned secondary analysis of the multicenter PREVENT trial, reported by W.Gregory Hundley, MD, FACC, of Pauley Heart Center, Division of Cardiology, Department of ...

The ASCO Post

November 19, 2025

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

On November 6, 2025, the U.S. Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) for adults with high-risk smoldering multiple myeloma.

The ASCO Post

November 19, 2025

New Computational Tool Shows Strong Accuracy in Predicting Cancer Drug Targets

Using a computational tool, DeepTarget, physicians were able to predict both primary and secondary targets of small-molecule agents for cancer treatment, according to findings from a study published i...

The ASCO Post